Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells.
Yasumatsu
Ryuji
R
Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, 812-8582 Fukuoka, Japan.
Nakashima
Torahiko
T
Masuda
Muneyuki
M
Ito
Aya
A
Kuratomi
Yuichiro
Y
Nakagawa
Takashi
T
Komune
Shizuo
S
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D045744:Cell Line, Tumor; D005260:Female; D006258:Head and Neck Neoplasms / Q000098:blood supply / Q000188:drug therapy*; D007124:Immunoenzyme Techniques; D007150:Immunohistochemistry; D007211:Indoles / Q000627:therapeutic use; D051379:Mice; D008807:Mice, Inbred BALB C; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D020913:Perindopril / Q000627:therapeutic use*; D011401:Promoter Regions, Genetic / Q000187:drug effects; D012333:RNA, Messenger / Q000187:drug effects; D020133:Reverse Transcriptase Polymerase Chain Reaction; D042461:Vascular Endothelial Growth Factor A / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D007211:Indoles; D012333:RNA, Messenger; D042461:Vascular Endothelial Growth Factor A; C053500:perindoprilat; D020913:Perindopril